Operate Vocal, a content distribution and digital publishing platform for creators. Host niche communities on Vocal for diverse rich media content, boosting visibility. Now — the numbers.
The biggest line carries real weight, but it doesn’t decide everything on its own.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
An average decline of 7% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
Executives buying with their own money is usually read as confidence in the company’s future.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $3.1M a year. A small number, but proof the product has real buyers.
It met or beat analyst expectations in 6 of the last 6 quarters — consistency is a promise kept.
Over the last 12 months, company executives reported 42 buys and 0 sells. Management buying with its own money is usually read as a good sign.
A loss of $7.6M against $3.1M in annual sales.
This stock swings about 6.7 times as much as the market average. Big rallies — and big drops — can both happen fast.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.